![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Baber RJ, Templeman C, Morton T, Kelly GE, West L. 1999. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 2:85–92.
- Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KD, Weinberg CR. 1995. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. Journal of Clinical Endocrinology & Metabolism 80:1685–1690.
- Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM. 2002. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. Journal of the Society for Gynecology Investigation 9: 238–242.
- Barbieri RL. 1992. Hormone treatment of endometriosis: the estrogenthreshold hypothesis. American Journal of Obstetrics & Gynecology 166:740–745.
- Björn I, Bäcksröm T. 1999. Drug related negative side-effects is a common reason for poor compliance in hormone replacement replacement therapy. Maturitas 32:77–86.
- Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. 1998. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstetrics & Gynecology 92:722–727.
- Carmignani LO, Pedro AO, Costa-Paiva LH, Pinto-Neto AM. 2010. The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas 67:262–269.
- Coe R. 2002. It's the effect size, stupid: What effect size is and why it is important.
- Colacurci N, Zarcone R, Borrelli A, De Franciscis P, Fortunato N, Cirillo M et al.2004. Effects of soy isoflavones on menopausal neurovegetative symptoms. Minerva Ginecologica l56:407.
- Knight DC., Howes JB, Eden JA. 1999. The effect of Promensil™, an isoflavone extract, on menopausal symptoms. Climacteric 2:79–84.
- Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. 2000. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 3:161–167.
- Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G. 2011. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. Archives Gynecology and Obstetrics 283:1319–1323.
- Levis S, Griebeler ML. 2010. The role of soy foods in the treatment of menopausal symptoms. Journal of Nutrition 140:2318S–2321S.
- Lima SM, Yamada SS, Reis BF, Postigo S, Galvão da Silva MA, Aoki T. 2013. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Maturitas 74:252–258.
- Murkies AL, Wilcox G, Davis SR. 1998. Phytoestrogens. J Clin Endocrinol Metab 83:297–303.
- Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R. 2007. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study. Maturitas 58:249–258.
- Oxford-Center for Evidence Based Medicine. Available at: http://www.cebm.net/criticalappraisal.asp
- Pastore LM, Carter RA, Hulka BS, Wells E. 2004. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 49:292–303.
- Sturdee DW, MacLennan AH. 2006. Not all placebos are equally pleasing. Climacteric 9:401–403.
- Tedeschi C, Benvenuti C, Research Group EG. 2012. Comparison of vaginal gel isoflavones versus no topical treatment in vaginal dystrophy: results of a preliminary prospective study. Gynecological Endocrinology 28: 652–654.
- Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. 2000. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo- controlled study. Menopause 7:236–242.
- Utian WH.1980. The place of oestriol therapy after menopause. Acta Endocrinologica (Copenhagen) 233:51–56.